Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis
This book reviews successes and (remaining) challenges in vaccine development for the selected Neglected Tropical Diseases (NTD) of Leprosy, Leishmaniasis, Meliodoisis and Tuberculosis, which are a continuous burden for millions of people in affected areas worldwide. Written by frontline researchers...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer International Publishing
2023.
|
| Edición: | 1st ed. 2023. |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009741106406719 |
Tabla de Contenidos:
- Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network
- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK)
- Part I: Leprosy
- 2. Leprosy challenges to vaccine developers
- (Dr Hua Wang, University of Glasgow, UK)
- 3. Leprosy vaccine development
- (Dr Khushboo Borah, University of Surrey, UK)
- Part II: Tuberculosis
- 4. Biomarkers in tuberculosis vaccine development
- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa)
- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK),
- Animal models for tuberculosis (Dr. Hao Li, China Agricultural University, Beijing, China)
- 7. BCG vaccination
- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK)
- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK)
- 9. Fermentation in vaccine development (BCG) (Dr. Joanna Bacon, Public Health England, UK Government, London, UK)
- Part III: Leishmaniasis: 10. Human leishmaniasis vaccination
- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran)
- 11. Aspects of human leishmaniasis vaccine use
- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria)
- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK)
- 13. Canine leishmaniasis vaccines
- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK)
- Part IV: Melioidosis
- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India)
- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria).
